Progress
WP1 | Project management, risk assessment and ethical issues 38%
WP2 | Specifications, requirements and benchmarking 75%
WP3 | Multifunctional biomaterials and REBORN technologies 4%
WP4 | Conventional and advanced in vitro test 60%
WP5 | TRL 5 translation and demonstration 0%
WP6 | Pre-clinical validation 0%
WP7 | Clinical specifications, regulatory aspects and cost assessment 0%
WP8 | Business cases development, exploitation and dissemination 38%